By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Foundation Medicine said today that it will use its genome sequencing and analysis services to identify genetic biomarkers and potential companion diagnostics for oncology drug candidates for Sanofi.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.